These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10599407)

  • 1. [How much does it cost eradicating Helicobacter pylori in Argentine?].
    Man F
    Acta Gastroenterol Latinoam; 1999; 29(4):285-7. PubMed ID: 10599407
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes of initial noninvasive Helicobacter pylori testing in U.S. primary care patients with uninvestigated dyspepsia.
    Ladabaum U; Fendrick AM; Scheiman JM
    Am J Gastroenterol; 2001 Jul; 96(7):2051-7. PubMed ID: 11467631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit analysis of Helicobacter pylori screening.
    Leivo T; Salomaa A; Kosunen TU; Tuominen R; Färkkilä M; Linna M; Sintonen H
    Health Policy; 2004 Oct; 70(1):85-96. PubMed ID: 15312711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of Helicobacter pylori "test and treat" for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis.
    You JH; Wong PL; Wu JC
    Scand J Gastroenterol; 2006 Jan; 41(1):21-9. PubMed ID: 16373272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment?
    Pohl H; Finlayson SR; Sonnenberg A; Robertson DJ
    Aliment Pharmacol Ther; 2005 Sep; 22(6):529-37. PubMed ID: 16167969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
    Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
    Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori.
    Vakil N; Rhew D; Soll A; Ofman JJ
    Am J Gastroenterol; 2000 Jul; 95(7):1691-8. PubMed ID: 10925969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of and satisfaction with a Helicobacter pylori "test and treat" strategy compared with prompt endoscopy in young Asians with dyspepsia.
    Mahadeva S; Chia YC; Vinothini A; Mohazmi M; Goh KL
    Gut; 2008 Sep; 57(9):1214-20. PubMed ID: 18441005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradicating Helicobacter pylori in non-ulcer dyspepsia may not be cost effective.
    Formoso G; Maestri E; Magrini N; Koch M; Capurso L; Liberati A
    BMJ; 2001 Mar; 322(7285):557. PubMed ID: 11263460
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.
    Klok RM; Arents NL; de Vries R; Thijs JC; Brouwers JR; Kleibeuker JH; Postma MJ
    Clin Ther; 2005 Oct; 27(10):1647-57. PubMed ID: 16330302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.
    Vakil N; Zullo A; Ricci C; Hassan C; Vaira D
    Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1304-8. PubMed ID: 18774949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States.
    Rupnow MF; Chang AH; Shachter RD; Owens DK; Parsonnet J
    J Infect Dis; 2009 Oct; 200(8):1311-7. PubMed ID: 19751153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for health.
    de Vries R; Klok RM; Brouwers JR; Postma MJ
    Vaccine; 2009 Feb; 27(6):846-52. PubMed ID: 19084566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The health economics of Helicobacter pylori infection.
    Moayyedi P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication therapy for Helicobacter pylori.
    Vakil N; Megraud F
    Gastroenterology; 2007 Sep; 133(3):985-1001. PubMed ID: 17854602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastritis, dyspepsia and Helicobacter pylori].
    de Korwin JD
    Rev Prat; 2000 Sep; 50(13):1431-6. PubMed ID: 11019635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H. pylori testing and endoscopy for dyspepsia in primary care. Test and treat seems best.
    Lancaster Smith MJ
    BMJ; 2001 Aug; 323(7308):343. PubMed ID: 11548682
    [No Abstract]   [Full Text] [Related]  

  • 18. Empiric eradication therapy or endoscopy in Helicobacter pylori-positive patients?
    Lugannani C; Strickland C
    J Fam Pract; 1999 Dec; 48(12):998. PubMed ID: 10628582
    [No Abstract]   [Full Text] [Related]  

  • 19. Implications for treatment: pH, Helicobacter pylori or alternative approaches?
    Chey WD
    Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():17-8, 21-4. PubMed ID: 15755271
    [No Abstract]   [Full Text] [Related]  

  • 20. Economic evaluations in medicine: still more questions than answers?
    Grossi E
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):347-50. PubMed ID: 9789124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.